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Abstract
Angiogenesis, the development of new vasculature, is a critical process in the
growth of new tumors. Driven by a goal to understand this aspect of cancer
proliferation, we develop a discrete computationally optimized mathemati-
cal model of angiogenesis that specializes in intercellular interactions. We
model vascular endothelial growth factor spread and dynamics of endothelial
cell movement in a competitive environment, with parameters specific to our
model calculated through Dependent Variable Sensitivity Analysis (DVSA)
and experimentally observed data. Through simulation testing, we find the
critical limits of angiogenesis to be 102 m and 153 m respectively, beyond
which angiogenesis will not successfully occur. Cell density in the surround-
ing region and the concentration of extracellular matrix fibers are also found
to directly inhibit angiogenesis. Through these three factors, we postulate
a method for establishing criticality of a tumor based upon the likelihood
of angiogenesis completing. This research expands on other work by choos-
ing factors that are patient-dependent through our specialized Cellular Potts
mode, which serves to optimize and increase accuracy of the model. By doing
such, we establish a theoretical framework for analyzing lesions using angio-
genetic properties, with the ability to potentially compute the criticality of
tumors with the aid of medical imaging technology.
Keywords: Angiogenesis, Cellular Automata Models, Tumor Modelling
1. Introduction
Over 7 million people die every year of cancer, killed by false diagnoses,
improper treatments, and excessive medications. Although many aspects of
Preprint submitted to Intel STS 2015 October 8, 2018
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cancer proliferation and detection have been documented over the years, one
newly emerging category is the field of angiogenesis. Angiogenesis is the de-
velopment process of new blood vessels in the cardiovascular system to get
oxygen and nutrients to all systems in the body, a process that drives cancer
proliferation. Research on cancer-induced angiogenesis focuses on the rela-
tionship between blood vessels and cancerous lesions, detailing the mutual
growth in the interdependent processes. Mathematical models of angiogen-
esis can simulate the system to analyze stresses on the tumor, but current
models are very theoretical with minimal practical applications. This paper
focuses on patient-based factors, borrowing from previous models, to create
a fully integrated system. In the process, I theorize a high level specialized
mechanism for cellular mechanics that optimizes computation and accuracy
in the system.
2. Biological Background
2.1. Angiogenesis
Angiogenesis, the development of new blood vessels from existing vascu-
lature, is an integral part of many physiological processes in the human body,
including wound healing, tumor growth and diabetes. Growth factors trig-
ger a biochemical pathway in the blood vessels, causing hemangioblasts in
the system to specialize into vascular endothelial cells.(Karamysheva, 2008).
These new endothelial cells form a new blood vessel with branches off from
the existing capillary and migrates through chemotaxis toward the source of
these growth factors.[? ]
2.2. Cancer Induced Angiogenesis
Cancerous cells, like all other cells, require basic nutrients and oxygen to
grow and proliferate. Yet due to the high oxygen consumption of cancerous
cells, the tumor is often hypoxic (lack of oxygen) and its growth stagnates.
While in this hypoxic state, tumors begin secreting growth factors that are
triggers for angiogenesis (Nishida Yano, 2006). While in hypoxia, the tumor
is at its critical limit, where the vascular response to the secreted chemicals
directly affects the lifespan of the tumor. If angiogenesis occurs, then a blood
vessel is attached very close to the tumor, allowing it to expand and perhaps
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metastasize. If angiogenesis fails to occur, then the tumor will continue sub-
sisting and not growing until the immune system triggers forced apoptosis on
the cell. Angiogenetic growth factors will continue flowing, until the tumor
receives negative feedback through oxygen.
2.3. Vascular Endothelial Growth Factor
VEGF ( Vascular Endothelial Growth Factor) is a family of homodimeric
glycoproteins known to trigger angiogenesis and induce vascular permeabil-
ity in endothelial cells. Previous studies have shown that VEGFA is the
primary growth factor secreted by tumors when deprived of oxygen (Gab-
hann Popel, 2003). Endothelial cells have multiple receptors for the VEGF
family, VEGFR1, VEGFR2, and VEGFR3. Of theses, only VEGFR2 ini-
tializes the biochemical process for angiogenesis, but the other members of
the VEGFR family compete for VEGFA, resulting in a complex chemical
system. Once the new vasculature is formed, the tip cell of the blood vessel
moves up the concentration gradient of VEGF towards the tumor. (Unless
specifically mentioned, VEGFR will refer to VEGFR2, and VEGF and will
refer to VEGFA)
3. Tumor Angiogenesis Modelling
A sudden surge in biological research in angiogenesis in the late 20th cen-
tury has triggered many mathematical efforts to model the process. Initial
simulations were continuous models focused either on tip cell dynamics for
endothelial cells (Szab) or biochemical interactions with growth factors (Gab-
hann Popel, 2003) . Following initial combinatory models which attempted
to link the dynamical and chemical aspects, the first complete discrete model
of angiogenesis came out in 2006 (Norrby, 2006). Later on, further research
expanded the two aspects, as well as using a 3D environment, taking the first
steps to realistic simulations of cancer-induced angiogenesis.
Our model builds upon the model of Zheng, with an additional emphasis
on cellular mechanics. In line with the goal for integration of this model
with medical technology, we develop a discrete dynamic system to analyze
all aspects of the environment. The two primary segments of this model
are the cellular environment and the chemical system that inhabits it. For
the chemical aspect, we focus on biochemical interactions like VEGF uptake
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by endothelial cells and intra-chemical interactions like diffusion, dissolution,
and decay. When examining forces that influence the cellular environment,
we theorize that the normal noncancerous cells surrounding the tumor play a
distinctly important role in the probability of angiogenesis occurring. Thus,
our model develops an adaptation of the Cellular Potts cellular automata
model that places special emphasis on the normal cell surrounding the tumor.
We integrate the biochemical model and the cellular mechanics model
together on a multi-scale level. Although these models disagree on temporal
and spatial scales, we manipulate the models to sacrifice accuracy in ex-
change for a well-integrated and more computationally efficient model. The
environment we design is a 3d collection of points, with the tumor located
upon the upper right corner of the environment, and blood vessels orthogo-
nal to the X and Y axes through the origin (Figure 1). Since cellular growth
mechanics are anomalous in cancerous cells, we place the tumor outside the
system to prevent interference in the model. The blood vessel in question is
also designed to be outside the environment, and intersecting the environ-
ment at the origin, where angiogenesis will take place. By manipulating the
environment, through placement of the blood vessel and tumor, we prevent
aberrant results and increase future reproducibility.
Figure 1: Location of critical components in the cellular environment for the model
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4. Biochemical Model of VEGF Interactions
4.1. Secretion of VEGF
We describe the level of VEGF being secreted from the tumor in a hypoxic
environment through its distance from the blood vessel. Having established
that all the body cells in the environment are not hypoxic, we reduce com-
plexity of the system by substituting the concentration of the oxygen with
r, the distance of the tumor from the blood vessel. A rudimentary diffusion
substitution between oxygen and radius yields Equation 1. The secretion of
VEGF occurs only from the center of the tumor, a point source, with Thus,
the VEGF secretion will decrease to zero as angiogenesis proceeds.
dφ
dt
=
ks
r3
(1)
4.2. Interchemical Interactions
We model typical chemical interactions outside cells such as diffusion
and decay, which affect spread of the growth factor. Borrowing from previ-
ous research (Gabhann Popel, 2003), this model simulates a linear decay of
VEGF. Equations 2 and 3 represent the continuous differential equation and
partially-solved PDE versions of the decay equation respectively. We sim-
plify the PDE by connecting it to the previous time step, thus discretizing
the variable and increasing computational efficiency. (Equation 4).
dφ
dt
= −kdecφ (2)
φ(t) = φie
−φt (3)
φ(t) = φ(t− 1)e−φ (4)
Previous research in VEGF modelling (Jain, 2008) described VEGF diffusion
in only 1 dimension. To increase accuracy and link the simulation to a
3D environment, we implement a 3D model of diffusion, radiating from the
point source of VEGF. We derive Ficks law to develop a mechanism to model
concentration changes over time. Our model of VEGF diffusion is based upon
Ficks first (Equation 5) and second laws (Equation 6), where J represents
the flux of chemical movement, and D is the diffusion constant. We deviate
from Ficks continuous law by establishing a variable concentration gradient,
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and so we must discretize diffusion using the previous time step. In this new
equation (Equation 7), the specified location is categorized as a receiver of
diffused chemicals, with the 6 neighboring cells as the sources of chemicals.
J = −D∇φ (5)
∂φ
∂t
= D
∂2φ
∂t2
(6)
φ(t) = φ(t− 1)− 1
6
D
6∑
n=1
∇φn (7)
4.3. VEGF Pathway for Angiogenesis
VEGF and its complement receptor family VEGFR are the gateway to he-
mangioblast specialization into endothelial tissue. Unlike previous research,
which model just the VEGF-A proteins and VEGFR2 receptors, this model
extends to VEGF-B and VEGFR1. These chemicals do not trigger angio-
genesis but they indirectly inhibit the target reaction.
V EGFA+ V EGFR1
k1→ ComplexV EGFR1
V EGFB + V EGFR1
k2→ ComplexV EGFR1
V EGFA+ V EGFR2
k3→ ComplexV EGFR2
V EGFB + V EGFR2
k4→ ComplexV EGFR2
ComplexV EGFR1
k5→ V EGFR1
ComplexV EGFR2
k6→ V EGFR2
Applying the law of mass action to this set of chemical reactions gives us
the rate of cellular use of VEGF-A. Using the steady-state solution obtained
from Michaelis-Mentin kinetics from Figure 2, we can find the exact timing
of successful angiogenesis.
d[V EGFA]
dt
= −k1[V EGFA][V EGFR1] (8)
d[V EGFR1]
dt
=− k1[V EGFA][V EGFR1] (9)
− k2[V EGFB][V EGFR1] + k5[ComplexV EGFR1]
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4.4. State Function and Integration
Integration of the biochemical and the mechanical models occurs by as-
suming the same physical and temporal scale. Resolution is unimportant,
since concentration level will not greatly differ, so we lose minimal accuracy,
yet by linking the two models, and speed it up by at least 3 times. This thus
gives way to an overall state model which allows us to find the new VEGF
concentration after a single time step in 1 calculation.
∂φ
∂x
=
ks
r3
− kdecφ−D∇φ− k1[V EGFA][V EGFR1] (10)
5. Dynamic Mechanical Model of Intercellular Interactions
We utilize the Cellular Potts model to describe the cellular environment,
a collection of cells floating in the interstitial fluid alongside the extra matrix
fibers. Unlike previous cellular automata models (Bauer, May 2007) , this
lattice model has only been established in the literature, and never utilized.
The techniques we use to implement a Cellular Potts model are derived from
similar methods in other cellular automata and implementations of other
processes using this algorithm.
The environment is defined as a 3 dimensional set of lattice points, all of
which are assigned a non-unique Cell ID, defined as . This cell ID is used
to differentiate between the extracellular matrix, the interstitial fluid, and
the individual cells. Temporal updates to the lattice site are made upon
the tendencies of the system are to shift toward minimal potential energy
and maximum entropy. Every time step, though Monte-Carlo simulation,
the algorithm loops through pairs of neighboring lattice points, and virtu-
ally switches all the cell IDs to update. In accordance to the Boltzmann
probability distribution, we determine whether the transaction is accepted
or rejected (Equation 11). Should the energy increase in the system, the
change is sometimes accepted to ensure that a false equilibrium doesnt pre-
vent the simulation from completing angiogenesis.
Pacceptance(∆E) = e
−∆E
t (11)
In this Cellular-Potts model, we analyze four key aspects of cellular inter-
actions, the elasticity of the cell, and cohesion between cells, cellular senes-
cence, and chemotaxis (for endothelial cells)
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5.1. Cellular Elasticity
Cellular elasticity refers to the potential energy driving expansion and
contraction of the cell. We look at the three most important aspects of
cellular elasticity in this model, volume elasticity, surface elasticity and the
diffusion based elasticity. A cell that is growing will expand to the optimal
size, and the physical definition of elasticity due to volume expansion says
potential energy is proportional to the cube of the radius of the cell (Equation
12). Surface area, which dictates diffusion rate and thus metabolism, is
also taken into consideration. Potential energy from surface area tension
(Equation 13) is proportional to the square of difference in surface areas.
One novel aspect that we model is the surface area to volume ratio, which
dictates relative diffusion, and plays a role in correcting cell shape. Should the
diffusion rate be inhibited by cell shape, then the cell tends toward its optimal
configuration, a sphere. We model this as a piecewise function (Equation 14)
which acts only when the surface area to volume ratio reaches a threshold.
EV olume = kv(vcurrent − vtarget)3 (12)
ESA = ksa(SAcurrent − SAtarget)2 (13)
Etension =
{
0 : 1
2
< V olume
SA
< 2
kt ∗ (V olumeSA )
4
: V olume
SA
< 1
2
or V olume
SA
> 2
(14)
5.2. Chemotaxis with VEGF and CXCLS
Studies show that VEGF triggers endothelial cell migration up a concen-
tration gradient. Empirical evidence suggests that the speed at which the
cell migrates is proportional to the chemical gradient (Equation 15), with
the correlation coefficient being the sensitivity of the cell. Since intercellu-
lar forces among the inner endothelial cells negate the effects of chemotaxis,
this chemotactic force acts most upon the tip cell which interacts with the
extracellular matrix and provides much of the direction guiding for the new
vessel being formed.
Echemotaxis = kchemo∇φ (15)
5.3. Cellular Cohesion
We take into consideration cohesive bonds formed between the cells in
the system. For the purpose of this simulation, we disregard the cohesive
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forces inside a cell, and also the viscosity between the interstitial fluid and
the matrix fibers. Since all of the objects in the system have approximately
the same density, and the lattice points are isochoric, and so we develop
the mass of the system into the friction coefficients. We model the cellular
cohesion is the sum of the coefficients of its neighbors which dont belong to
the same cell (Equation 16).
Ecohesion(i) =
6∑
j=1
c(µ(i),µ(j))) (16)
5.4. Cellular Senescence
One major flaw that existed with previous models is the absence of cel-
lular reproduction and cellular senescence. The surrounding environment
of cells was static, and created discrepancies from physical angiogenesis ex-
periments. The time-scale of angiogenesis is long enough for all cells to
reproduce at least two times and for 20 percent of the cells to die. We
establish that a cell reproduces approximately every 20 time steps, and that
cellular senescence has a 5% chance of occurring for a cell. The probability
model generated for cellular reproduction (Equation 17) ensures that 95%
cells do reproduce within 15-25 time steps. The probability model generated
for cellular senescence (Equation 18) ensures that 95% cells will die within
1030 reproductions.
Preproduction(t) =
1
2
[1 + erf(t− tr)] (17)
Preproduction(t) =
1
2
[1 + erf(
t− tr ∗ ts
25
√
2
)] (18)
6. Model Testing Parameters
The mathematical model was tested in a simulation created in C++,
with a parallelized structure for optimized DVSA (Dependent Variable Sen-
sitivity Analysis). Numerical analysis is done through a structure analyzer
which compares cell shape, size, and structure. Graphical analysis uses 3d
space-filling models of the lattice structure, which allows for easy analysis of
endothelial cell migration.
The minor disconnect between the modified Cellular Potts model and
the biochemical model are resolved by analytically solving the VEGF state
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equation through Runge-Kutta algorithms (San Joaquin Delta College), an
efficient method for solving these partial differential equations.
Research upon cancer angiogenesis modeling has experimentally uncov-
ered the values for many constants used in this mathematical model. Samples
include diffusion rate, decay rate of VEGF, and the relative adhesion con-
stants between the cells. Yet, many constants such as relative tensile strength
of the cells and chemotactic sensitivity to VEGF to endothelial cells, have
not been developed and require a sensitivity analysis. By performing this
sensitivity analysis, we find the optimal value of the constant in question
and also the effect of slight change of the constant upon the system. To do
such we utilize regression-based analysis, due to the high computational cost
of running the operation.
Name Value Equation
ks 1.531 1
kdec 0.011552453 2
D 1 5
[V EGFR]init 125.6 8
temperature (t) 1000 11
kv 0.4 12
ksa .4 13
kt 1 14
kchemo .15 15
tr 20 17
ts 20 17,18
Table 1: Constants for the simulation derived from previous research for our discretized
variables
7. Computational Results and Discussion
To test this mathematical model, we ran the model through multiple sim-
ulations. Particular factors manipulated that were of interest included cohe-
sive strength, VEGF Sensitivity of endothelial cells and the level of migration
for cells. Furthermore, to ensure that the simulation was following proper
procedure, we monitor the body cell movement and VEGF concentration
throughout the process. While performing these tests, we obtain the data
from three major locations: a visual examination, the raw variable stream
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from the simulation, and the result on whether angiogenesis completed or
not.
7.1. Cohesion Strength
In general, manipulation in the cohesive strength alters the shapes of
cells and the distance between cells. Typically, body cells will have similar
cohesion constants, and not much variance will occur. However as seen by
tip cell research, the cohesion coefficients between the endothelial cells and
interstitial fluid will vary from location to location.
Figure 2: Space filling model for simulation with high cohesion forces. The entire angio-
genesis environment is displayed on the left, and just the new vasculature on the right
Our testing shows that when the cohesion coefficient is extremely high
(Figure 3), clumping occurs and the space repression factors overpower the
force of chemotaxis. Such is remedied in two manners, either by triggering
cancer angiogenesis in a neighboring vasculature or by adjusting the environ-
ment by secreting extracellular matrix fibers.
7.2. VEGF Sensitivity
Beyond the initial biochemical pathway that triggers angiogenesis, the
main factor driving endothelial cells is VEGF chemotaxis on endothelial cells.
Thus, this is not a factor that can be manipulated in the real world. However,
by analyzing how VEGF causes cells to move helps us calibrate the proper
sensitivity to ensure that angiogenesis actually occurs. When the sensitivity
is too high, all the endothelial cells move on the concentration gradient, but
cause little, if any, motion for body cells. The endothelial cell begins disre-
garding its elastic constraints and deforms into odd shapes. When VEGF
sensitivity is low, the endothelial cell begins acting like a normal body cell.
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Overall migration is limited to 2-3 micrometers and the new vasculature
looks like a stub. The most optimal point is where the each endothelial cell
migrates 20 um, and the width of the blood vessel is 10 micrometers in di-
ameter. At this optimal point, the body cells shake around in their place,
moving randomly, creating no migration power. The cellular movement due
to VEGF is optimal for endothelial cells at VEGF sensitivity in Table 1.
(Figure 4)
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Figure 3: Cell movement for endothelial cells (left) and for body cells (right)
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7.3. Cell Density
With our increased emphasis on the body cells, we discuss the effect of
randomness of inputs on the system. Although for simulation purposes, a
rectangular grid of evenly shaped and spaced out cells proves useful for re-
producibility, it isnt effective for real-life situations. Understanding the high
entropy around the body, we randomize the environment, and collect data
on angiogenesis completion. The most common source of randomness is a re-
arrangement of the surrounding cells and matrix fibers among the interstitial
fluid. We examine the effect of randomizing the environment upon the rate
of angiogenesis. This change in environment does alter the rate of cancer
angiogenesis by as much as 50%, and in some cases inhibited angiogenesis.
When we double the size of the initial cells and their optimal sizes, thus
making the beginning cells take up significantly more room, the likelihood
of angiogenesis decreases by almost 30%. Interestingly, when the cell size is
manipulated, the time taken for angiogenesis doesnt change much, yet the
probability of angiogenesis occurring in a reasonable time period decreases
significantly. If cellular density is too high due to increased sizes, then initial
rate of tip cell migration is affected, and probability of angiogenesis comple-
tion is reduced. However, if the tip cell does maintain a stable initial rate,
then the cell density plays only a minor role in angiogenesis speed.
7.4. Body Cell Movement
This data shows the tracking of cell size as we progress through cancer
angiogenesis. In this particular simulation, all the cells were located in lattice
structure, and cell sizes were monitored for external stimuli. The increase
in cell size is attributed to a force applied by the endothelial body, and the
decrease in cell size, a movement away from the cell. In terms of the cellular
environment, we see a pressure being put upon the side of the cube by the
newly emerging endothelial cell. Although most of the cells stabilize after the
first reproduction (after 20 time steps), the cells near the side of the lattice,
and the size of the cell increases a result.
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Figure 4: Results of a simulation that tracked body cell sizes to monitor the movement
of endothelial cells throughout the environment
7.5. Cell Location
Clearly, the location of the tumor with respect to the vasculature makes
a huge difference. We tested an experiment that modified the size of the
environment (and thus the location of the cell), and measured the difference
in time taken to complete angiogenesis. The model was calibrated with min-
imum distance for angiogenesis to occur at 102 um (Alarcon, 2006), and as
mentioned earlier, we analytically calculated the stopping point of angiogen-
esis at approximately 153 um (with optimal variables and dependent upon
initial cell configuration. Beyond this range, the rate of decay and diffusion
reduce the supply of growth factor to the point where chemotaxis cannot
drive angiogenesis.
After testing for correlations between speed of angiogenesis and the dis-
tance related, we extrapolate the following relationship.
7.6. VEGF Distribution
VEGF is the driving factor in the entire environment, and so we observe
the concentration of the chemical as angiogenesis takes place. Initially, af-
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ter the tumor begins experiencing hypoxia, the concentrations increase in
the area of the tumor, proving that the tumor is properly secreting VEGF.
VEGF begins to spread and begins reaching appreciable quantities in the
location of the blood vessel. Yet, due to the rapid rate of reaction for the
angiogenesis pathway for endothelial cells, the difference cannot be seen un-
til the angiogenesis pathway completes and the reaction stops occurring in
the region. At that point, we see the VEGF concentration shoot up. This
acts as a partial deterrent to the VEGF chemotaxis, but to overcome the
initial spike in concentration, we notice that the tension force applied by the
endothelial cells. As the angiogenesis completes, we reach equilibrium, and
the overall VEGF gradient present removes. We ensure the veracity of this
VEGF proliferation model by comparing these trends with previous research
(Norrby, 2006).
Figure 5: Movement of VEGF throughout the environment over the time period of
angiogenesis (left to right, top to down)
7.7. 6.7 Completion of Cancer induced Angiogenesis (Criticality Detection)
Based upon the factors that we test above, we come to the conclusion
that the cellular density, the distance to the cell, and the overall density of
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the system are the most immediate and influential factors in angiogenesis.
Given that successful angiogenesis results in heightened proximity between
the tumor and the cardiovascular system, it has several implications for the
future proliferation of the tumor. Relieved from hypoxia, the cancer will con-
tinue growing and possibly metastasize. Thus, we can successfully say that
the chances of angiogenesis occurring at 102 um is 0% (it is unnecessary) and
also at 153 um (the upper limit). Furthermore, the success of angiogenesis
depends upon the cellular density and the number of cells in the region. We
can factor this into the probability through a calculated factor combining
the number of endothelial cells, and their surface area and volume. The
sensitivity of this variable depends upon the overall density of the system,
a weighted average of the level of extracellular proteins in the ECM. The
effect of cellular density is compounded upon the distance of the tumor, and
by integrating these factors, we can create an integrated probability model.
With this probability model, we can rudimentarily predict the criticality of
the tumor based upon the likelihood of angiogenesis occurring.
8. Final Words
The mathematical model developed in this work lays the theoretical foun-
dation for practical cancer spread algorithms in the future. Turning away
from typical models of cancerinduced angiogenesis, our project provides a
refreshing view on cancer proliferation. Using the Cellular Potts model we
not only consider more environment related factors, increasing accuracy, but
these new factors can be assessed through patient tests. We establish a set
of criteria for proliferation of a hypoxic tumor to occur; namely, the distance
of the tumor from the nearest vasculature system, the cell density, and the
concentration of interstitial fluid in the environment. Through these crite-
ria, we develop a set of guidelines for determining criticality of a particular
tumor.
Our foray into modeling cancer angiogenesis through new lenses opens up
many possible areas for new research. The development of our mathematical
model now allows for practical applications in mapping cancer angiogenesis.
Our model solves many of the previous problems that existed with previous
continuous and discrete simulations. This model is computationally faster,
which allows for quick repetitive simulations required in the analytical field.
Furthermore, the use of the modified Cellular Potts system allows for varied
input and manipulation of fundamental constants useful when dealing with
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diversified patients. Overall, the computational efficiency, input parame-
terization make this a model that serves well as a framework for practical
investigations of cancer proliferation through cancer-induced angiogenesis.
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